Jingqing Mu
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 9
-
- Nanoplatforms for cancer theranostics 6
- Graphene and Nanomaterials Applications 4
-
- Traditional Chinese Medicine Analysis 4
-
- Metabolomics and Mass Spectrometry Studies 4
- RNA Interference and Gene Delivery 2
-
- Analytical Chemistry and Chromatography 2
-
- Plant-based Medicinal Research 2
- Co-authors
- Shutao GuoHaiping ZhongNa YuZunkai XuXing‐Jie LiangYang XuZiqi ChenQiankun Ni
- Journals
- Nature Communications (1 paper)Nano Letters (2 papers)Chemical Engineering Journal (1 paper)
- Partner nations
- ChinaIranUnited States
In The Last Decade
Jingqing Mu
20 papers receiving 350 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 132
- Pharmaceutical Science 26
- Biomedical Engineering 147
- Molecular Medicine 12
- Complementary and alternative medicine 18
Countries citing papers authored by Jingqing Mu
This map shows the geographic impact of Jingqing Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingqing Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingqing Mu more than expected).
Fields of papers citing papers by Jingqing Mu
This network shows the impact of papers produced by Jingqing Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingqing Mu. The network helps show where Jingqing Mu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingqing Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 29 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 54 | |
| 16 | 2020 | 22 | |
| 17 | 2020 | 79 | |
| 18 | 2017 | 12 | |
| 19 | 2017 | 10 | |
| 20 | 2017 | 10 |
About Jingqing Mu
Jingqing Mu is a scholar working on Biomaterials, Complementary and alternative medicine and Pharmaceutical Science, having authored 20 papers that have together received 355 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Traditional Chinese Medicine Analysis (4 papers), Graphene and Nanomaterials Applications (4 papers), Analytical Chemistry and Chromatography (2 papers), RNA Interference and Gene Delivery (2 papers) and Plant-based Medicinal Research (2 papers). The work is most often cited by research in Biomaterials (132 citations), Pharmaceutical Science (26 citations) and Biomedical Engineering (147 citations). Jingqing Mu has collaborated with scholars based in China, Iran and United States. Frequent co-authors include Shutao Guo, Haiping Zhong, Na Yu, Zunkai Xu, Xing‐Jie Liang, Yang Xu, Ziqi Chen, Qiankun Ni, Xi Zhang and Ziqi Chen. Their work appears in journals such as Nature Communications, Nano Letters and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.